Abstract
AbstractCertain types of cells possess unique characteristics such as tumor homing and prolonged circulation in blood, which are worthy of being exploited in drug delivery carriers for cancer therapy. To improve the delivery efficiency, these cells are integrated with artificial nanocarriers and therapeutic agents to construct biomimetic drug delivery systems. This report provides an overview of recent advances in cell‐derived drug delivery systems for effective cancer treatment. The natural membranes of cells like red blood cells, cancer cells, leukocytes, stem cells, and so on, are extracted and used to form cell membrane–camouflaged nanocarriers, which take advantage of the outstanding biocompatibility and versatile functions of cell membranes. In addition, as an emerging field, biomimetic drug delivery platforms utilizing living cells are also introduced. Finally, the limitations of biomimetic drug delivery systems and the future outlook are discussed and proposed herein.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
